How should insulin glargine (long‑acting) and insulin glulisine (rapid‑acting) be prescribed, including dose calculations based on weight, for a 62‑year‑old male weighing 82 kg with a diabetic foot infection and newly diagnosed type 2 diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Prescription for Newly Diagnosed Type 2 Diabetes with Diabetic Foot Infection

For this 62-year-old male (82 kg) with diabetic foot infection and newly diagnosed type 2 diabetes, initiate a basal-bolus insulin regimen with insulin glargine 16.4 units once daily (at bedtime) and insulin glulisine 4 units before each meal, with dose adjustments based on glucose monitoring.

Initial Dose Calculation

Total Daily Dose (TDD)

  • Starting TDD = 0.3 units/kg/day for severe hyperglycemia (>300 mg/dL) or acute infection 1
  • Calculation: 0.3 units/kg × 82 kg = 24.6 units/day total
  • This assumes severe hyperglycemia given the diabetic foot infection and undiagnosed diabetes 1

Basal Insulin (Glargine)

  • Basal component = 50% of TDD 1
  • Glargine dose = 24.6 units × 0.5 = 12.3 units, round to 12 units once daily
  • Administer at bedtime (same time every evening) 2
  • Alternative calculation using FDA labeling: 0.2 units/kg = 16.4 units for insulin-naïve type 2 diabetes 2
  • Recommended starting dose: 16 units once daily at bedtime (using the more conservative FDA approach for newly diagnosed diabetes) 2

Prandial Insulin (Glulisine)

  • Prandial component = 50% of TDD, divided across 3 meals 1
  • Glulisine dose = (24.6 units × 0.5) ÷ 3 = 4.1 units per meal, round to 4 units
  • Administer 0–15 minutes before each meal 1
  • If patient has poor oral intake, give only 50% of planned dose (2 units) 3
  • Hold prandial insulin entirely if NPO 3

Dose Adjustments for This Patient's Specific Context

Infection-Related Considerations

  • Acute infection increases insulin resistance; the calculated doses are appropriate 1
  • Monitor glucose every 2–4 hours initially, then before meals and bedtime 3
  • Target range: 100–180 mg/dL (5.6–10.0 mmol/L) 1, 3

Safety Modifications

  • Age >65 years: Consider reducing TDD to 0.15–0.25 units/kg/day 3
  • For this 62-year-old, standard dosing is appropriate unless frail 3
  • If renal insufficiency present (common with diabetic foot infection): reduce total dose by 20–30% 3, 4
  • A study in patients with chronic kidney disease showed 0.25 units/kg/day had 50% less hypoglycemia than 0.5 units/kg/day without compromising control 4

Titration Algorithm

Basal Insulin Adjustment

  • Increase glargine by 2 units every 3 days to reach fasting glucose goal of 100–130 mg/dL 1
  • If fasting glucose remains >180 mg/dL after 2–3 days, increase by 4 units 1
  • For hypoglycemia (<70 mg/dL): reduce dose by 10–20% 1

Prandial Insulin Adjustment

  • Increase glulisine by 1–2 units per meal if 2-hour postprandial glucose >180 mg/dL 1
  • Add correction doses: 2–4 units if pre-meal glucose >250 mg/dL (13.9 mmol/L) 3
  • Titrate each meal dose independently based on the corresponding postprandial glucose 1

Administration Instructions

Injection Technique

  • Rotate sites within abdomen, thigh, or deltoid 2
  • Use a new needle for each injection 2
  • Do not mix glargine with any other insulin 2
  • Glargine: clear and colorless solution; discard if cloudy 2

Timing

  • Glargine: once daily at the same time (recommend 8 PM) 2
  • Glulisine: 0–15 minutes before each meal 1
  • Never administer rapid-acting insulin at bedtime (increases nocturnal hypoglycemia) 3

Critical Pitfalls to Avoid

  • Never use sliding-scale insulin alone without basal insulin – associated with poor control and higher complication rates 3
  • Do not use premixed insulins (70/30,75/25) in hospitalized patients – unacceptably high hypoglycemia rates 3
  • Do not inject into areas of lipodystrophy or skin thickening – impairs absorption 2
  • Avoid intravenous or insulin pump administration of glargine – subcutaneous only 2
  • Do not abruptly stop oral agents if patient was on any – risk of rebound hyperglycemia 5

Monitoring Requirements

  • Glucose checks: before each meal and at bedtime (minimum 4 times daily) 3
  • Increase frequency to every 2–4 hours during initial stabilization 3
  • Document all hypoglycemia episodes (<70 mg/dL) and adjust regimen 3
  • If >50% of readings above target for 2 weeks: increase insulin by 2 units 3
  • If >2 readings per week <80 mg/dL: decrease insulin by 2 units 3

Infection-Specific Considerations

  • Diabetic foot infection requires aggressive glucose control to optimize wound healing 6, 7
  • High-dose antibiotics and surgical debridement may affect insulin requirements 6
  • Insulin needs typically decrease as infection resolves; anticipate dose reductions 1
  • Consider adding metformin once infection controlled and renal function confirmed adequate (eGFR ≥45 mL/min) to reduce insulin requirements and weight gain 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.